Követés
amandine rovini
amandine rovini
Staff scientist, Neurit UR20218,Limoges, France
E-mail megerősítve itt: unilim.fr
Cím
Hivatkozott rá
Hivatkozott rá
Év
JNK activation and translocation to mitochondria mediates mitochondrial dysfunction and cell death induced by VDAC opening and sorafenib in hepatocarcinoma cells
KA Heslop, A Rovini, EG Hunt, D Fang, ME Morris, CF Christie, MB Gooz, ...
Biochemical pharmacology 171, 113728, 2020
722020
Bcl-2—Enhanced Efficacy of Microtubule-Targeting Chemotherapy through Bim Overexpression: Implications for Cancer Treatment
A Savry, M Carre, R Berges, A Rovini, I Pobel, C Chacon, D Braguer, ...
Neoplasia 15 (1), 49-IN17, 2013
612013
Olesoxime prevents microtubule-targeting drug neurotoxicity: selective preservation of EB comets in differentiated neuronal cells
A Rovini, M Carré, T Bordet, RM Pruss, D Braguer
Biochemical pharmacology 80 (6), 884-894, 2010
532010
Molecular mechanism of olesoxime-mediated neuroprotection through targeting α-synuclein interaction with mitochondrial VDAC
A Rovini, PA Gurnev, A Beilina, M Queralt-Martín, W Rosencrans, ...
Cellular and Molecular Life Sciences 77 (18), 3611-3626, 2020
482020
ROS-mediated EB1 phosphorylation through Akt/GSK3β pathway: implication in cancer cell response to microtubule-targeting agents
M Le Grand, A Rovini, V Bourgarel-Rey, S Honore, S Bastonero, ...
Oncotarget 5 (10), 3408, 2014
442014
Sequence diversity of tubulin isotypes in regulation of the mitochondrial voltage-dependent anion channel
TK Rostovtseva, PA Gurnev, DP Hoogerheide, A Rovini, M Sirajuddin, ...
Journal of Biological Chemistry 293 (28), 10949-10962, 2018
432018
Quantitative analysis of mitochondrial membrane potential heterogeneity in unsynchronized and synchronized cancer cells
A Rovini, K Heslop, EG Hunt, ME Morris, D Fang, M Gooz, AA Gerencser, ...
The FASEB Journal 35 (1), e21148, 2021
392021
The macrophage: a key player in the pathophysiology of peripheral neuropathies
Z Msheik, M El Massry, A Rovini, F Billet, A Desmoulière
Journal of Neuroinflammation 19 (1), 1-18, 2022
342022
Anti-migratory effect of vinflunine in endothelial and glioblastoma cells is associated with changes in EB1 C-terminal detyrosinated/tyrosinated status
A Rovini, G Gauthier, R Bergès, A Kruczynski, D Braguer, S Honoré
PLoS One 8 (6), e65694, 2013
342013
Statin-dependent modulation of mitochondrial metabolism in cancer cells is independent of cholesterol content
CF Christie, D Fang, EG Hunt, ME Morris, A Rovini, KA Heslop, ...
The FASEB Journal 33 (7), 8186-8201, 2019
302019
Probing membrane association of α-synuclein domains with VDAC nanopore reveals unexpected binding pattern
D Jacobs, DP Hoogerheide, A Rovini, Z Jiang, JC Lee, TK Rostovtseva, ...
Scientific reports 9 (1), 1-14, 2019
292019
Mathematical model of cancer growth controled by metronomic chemotherapies
N Andre, D Barbolosi, F Billy, G Chapuisat, F Hubert, E Grenier, A Rovini
ESAIM: Proceedings 41, 77-94, 2013
252013
Tubulin-VDAC interaction: molecular basis for mitochondrial dysfunction in chemotherapy-induced peripheral neuropathy
A Rovini
Frontiers in Physiology 10, 671, 2019
202019
The angiotensin II type 2 receptor, a target for protection and regeneration of the peripheral nervous system?
A Danigo, A Rovini, F Bessaguet, H Bouchenaki, A Bernard, F Sturtz, ...
Pharmaceuticals 14 (3), 175, 2021
132021
Lipids in regulation of the mitochondrial outer membrane permeability, bioenergetics, and metabolism
TK Rostovtseva, DP Hoogerheide, A Rovini, SM Bezrukov
Molecular basis for mitochondrial signaling, 185-215, 2017
122017
DNA methylation patterns in human iPSC-derived sensory neuronal differentiation
S Ankam, A Rovini, S Baheti, R Hrstka, Y Wu, K Schmidt, H Wang, ...
Epigenetics 14 (9), 927-937, 2019
112019
The Cholecystokinin Type 2 Receptor, a Pharmacological Target for Pain Management
A Bernard, A Danigo, S Bourthoumieu, M Mroué, A Desmoulière, F Sturtz, ...
Pharmaceuticals 14 (11), 1185, 2021
82021
Evidences of a Direct Relationship between Cellular Fuel Supply and Ciliogenesis Regulated by Hypoxic VDAC1-ΔC
M Meyenberg Cunha-de Padua, L Fabbri, M Dufies, S Lacas-Gervais, ...
Cancers 12 (11), 3484, 2020
82020
Restricting α-Synuclein Transport into Mitochondria by Inhibition of α-Synuclein-VDAC Complexation as a Potential Therapeutic Target for Parkinson’s Disease Treatment
M Rajendran, M Queralt-Martín, PA Gurnev, WM Rosencrans, A Rovini, ...
bioRxiv, 2022
42022
Mitochondria and Tumor Metabolic Flexibility: Mechanisms and Therapeutic Perspectives
A Rovini, KA Heslop, EN Maldonado
Elsevier, 2021
32021
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–20